SF
Publications
66
Views
27,579
Downloads
6,813
Supervised works
1
Items per page
1 - 66 of 66
Title Published in Access level OA Policy Year Views Downloads
Assessment of access and outcomes of kidney transplantation through the reforms of the Swiss organ allocation systemFrontiers in public health
accessLevelPublic
2025 118 109
Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO)Transplantation direct
accessLevelPublic
2025 4 14
Comparing variable and feature selection strategies for prediction - protocol of a simulation study in low-dimensional transplantation dataPloS one
accessLevelPublic
2025 13 27
Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in SwitzerlandKidney International Reports
accessLevelPublic
2025 94 129
Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative GlomerulonephritisKidney international reports
accessLevelPublic
2025 48 120
Invasive Candida infections in solid organ transplant recipients between 2008 and 2020American Journal of Transplantation
accessLevelPublic
2025 12 15
Surgical site infections, risk factors, and outcomes after liver transplantJAMA network open
accessLevelPublic
2025 71 151
Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort StudyBMC infectious diseases
accessLevelPublic
2024 62 94
BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort StudyAmerican journal of transplantation
accessLevelPublic
2024 45 81
Surgical site infections after kidney transplantation are independently associated with graft lossAmerican journal of transplantation
accessLevelPublic
2024 56 141
NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivationBlood advances
accessLevelPublic
2024 112 62
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort StudyFrontiers in immunology
accessLevelPublic
2023 157 46
CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantationLeukemia & lymphoma
accessLevelPublic
2023 74 63
Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocolDiagnostic and prognostic research
accessLevelPublic
2023 77 144
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Open forum infectious diseases
accessLevelPublic
2023 91 68
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Open forum infectious diseases
accessLevelPublic
2023 140 85
HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 eraHLA
accessLevelPublic
2023 104 84
The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort studyFrontiers in immunology
accessLevelPublic
2022 187 87
Use of statins after liver transplantation is associated with improved survival: results of a nationwide studyAlimentary pharmacology & therapeutics
accessLevelPublic
2022 149 180
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patientsBMC infectious diseases
accessLevelPublic
2022 141 78
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipientsAmerican journal of transplantation
accessLevelPublic
2022 241 115
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled TrialClinical infectious diseases
accessLevelPublic
2022 147 72
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantationBlood advances
accessLevelPublic
2021 315 121
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort studyPLOS ONE
accessLevelPublic
2021 321 344
Pre-transplant donor-specific HLA antibodies and risk for poor first-year renal transplant outcomes: results from the Swiss Transplant Cohort StudyTransplant international
accessLevelPublic
2021 247 325
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantationLeukemia
accessLevelPublic
2020 402 295
Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsyPediatric Transplantation
accessLevelRestricted
2020 408 2
Peripheral donor specific antibodies are associated with histology and cellular subtypes in protocol liver biopsies of pediatric recipientsTransplantation
accessLevelPublic
2020 371 183
High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantationBone Marrow Transplantation
accessLevelPublic
2019 456 141
Identification of seven novel HLA class I and II allelesHLA
accessLevelRestricted
2018 250 0
Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective studyBMC Nephrology
accessLevelPublic
2018 551 202
Factors associated with immune hemolytic anemia after pediatric liver transplantationPediatric Transplantation
accessLevelRestricted
2018 381 1
Donor-specific antibodies C1q-binding: improvement in kidney graft management?Transplant international
accessLevelRestricted
2017 481 0
Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC)Inflammatory Bowel Diseases
accessLevelRestricted
2017 580 1
Identification of 3 novel HLA-B alleles: B*08:173, B*18:72:03 and B*53:05:02HLA
accessLevelRestricted
2017 556 0
Immunogenicity of anti-HLA antibodies in pancreas and islet transplantationCell transplantation
accessLevelRestricted
2016 553 3
Analysis and monitoring of anti-HLA antibodies in solid-organ and stem cell transplantation : What to do? When should they be tested?
accessLevelPublic
2015 716 375
Kidney paired donation: a plea for a Swiss National ProgrammeSchweizerische medizinische Wochenschrift
accessLevelPublic
2015 718 350
Late antibody-mediated rejection by de novo donor HLA-DP-specific antibody after renal transplantation: a case reportHuman immunology
accessLevelRestricted
2014 572 0
Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantationTransplant immunology
accessLevelRestricted
2014 695 2
The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in childrenPloS one
accessLevelPublic
2013 725 404
Effects of an Interleukin-15 Antagonist on Systemic and Skeletal Alterations in Mice with DSS-Induced ColitisThe American journal of pathology
accessLevelRestricted
2013 559 0
HLA and non-HLA polymorphisms in renal transplantationSchweizerische medizinische Wochenschrift
accessLevelRestricted
2012 662 1
Posttransplant cellular immune reactivity against donor antigen correlates with clinical islet transplantation outcome: towards a better posttransplant monitoringCell transplantation
accessLevelRestricted
2012 612 0
Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe?Tissue antigens
accessLevelRestricted
2012 701 0
Contact with stimulated T cells up-regulates expression of peptidylarginine deiminase 2 and 4 by human monocytesEuropean cytokine network
2012 580 0
Do RANKL inhibitors (denosumab) affect inflammation and immunity?Osteoporosis international
accessLevelPublic
2011 701 929
Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantationAmerican journal of transplantation
accessLevelRestricted
2011 746 0
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipientsAmerican journal of transplantation
accessLevelRestricted
2011 666 0
Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantationTransplantation
accessLevelRestricted
2010 658 0
Early relapse of autoimmune glomerulonephritis after kidney transplantation despite antibody induction and triple-drug-based immunosuppressionTransplantation
accessLevelRestricted
2010 654 0
Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipientsClinical immunology
accessLevelRestricted
2010 648 0
RANKing bone resorption versus inflammation: Infection makes the decisionIBMS boneKEy
accessLevelPublic
2010 526 337
Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient miceArthritis and rheumatism
accessLevelRestricted
2010 541 0
Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cellsJournal of Cellular and Molecular Medicine
accessLevelPublic
2009 607 146
Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipientsTransplant international
accessLevelRestricted
2009 644 0
Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year markAmerican journal of transplantation
accessLevelRestricted
2009 978 6
In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosisAmerican journal of respiratory cell and molecular biology
accessLevelRestricted
2008 762 1
Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantationTransplantation
accessLevelRestricted
2008 924 0
Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantationAmerican journal of transplantation
accessLevelRestricted
2008 772 0
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansionBlood
accessLevelRestricted
2008 604 0
IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytesInternational immunology
accessLevelRestricted
2008 575 164
The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptorsArthritis Research and Therapy
accessLevelPublic
2007 238 167
Airway epithelial IL-15 transforms monocytes into dendritic cellsAmerican journal of respiratory cell and molecular biology
accessLevelRestricted
2007 620 1
Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantationSchweizerische medizinische Wochenschrift
accessLevelPublic
2006 528 347
Acute humoral rejection in kidney allograft following a third-party arterial transplantationAmerican journal of transplantation
accessLevelRestricted
2006 632 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack